These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 22830353)
1. Expression of stem cell markers, CD133 and CD44, in pediatric solid tumors: a study using tissue microarray. Mehrazma M; Madjd Z; Kalantari E; Panahi M; Hendi A; Shariftabrizi A Fetal Pediatr Pathol; 2013 Jun; 32(3):192-204. PubMed ID: 22830353 [TBL] [Abstract][Full Text] [Related]
2. Expression and clinical significance of stem cell marker CD133 in human neuroblastoma. Tong QS; Zheng LD; Tang ST; Ruan QL; Liu Y; Li SW; Jiang GS; Cai JB World J Pediatr; 2008 Feb; 4(1):58-62. PubMed ID: 18402255 [TBL] [Abstract][Full Text] [Related]
3. Aberrant expression of cancer stem cell markers (CD44, CD90, and CD133) contributes to disease progression and reduced survival in hepatoblastoma patients: 4-year survival data. Bahnassy AA; Fawzy M; El-Wakil M; Zekri AR; Abdel-Sayed A; Sheta M Transl Res; 2015 Mar; 165(3):396-406. PubMed ID: 25168019 [TBL] [Abstract][Full Text] [Related]
4. The clinicopathological and prognostic significance of CD24, CD44, CD133, ALDH1 expressions in invasive ductal carcinoma of the breast: CD44/CD24 expression in breast cancer. Kapucuoğlu N; Bozkurt KK; Başpınar Ş; Koçer M; Eroğlu HE; Akdeniz R; Akçil M Pathol Res Pract; 2015 Oct; 211(10):740-7. PubMed ID: 26298632 [TBL] [Abstract][Full Text] [Related]
5. Effect of EpCAM, CD44, CD133 and CD166 expression on patient survival in tumours of the ampulla of Vater. Piscuoglio S; Lehmann FS; Zlobec I; Tornillo L; Dietmaier W; Hartmann A; Wünsch PH; Sessa F; Rümmele P; Baumhoer D; Terracciano LM J Clin Pathol; 2012 Feb; 65(2):140-5. PubMed ID: 22130902 [TBL] [Abstract][Full Text] [Related]
6. CD133 and CD44 cell surface markers do not identify cancer stem cells in primary human gastric tumors. Rocco A; Liguori E; Pirozzi G; Tirino V; Compare D; Franco R; Tatangelo F; Palaia R; D'Armiento FP; Pollastrone G; Affuso A; Bottazzi EC; Masone S; Persico G; Nardone G J Cell Physiol; 2012 Jun; 227(6):2686-93. PubMed ID: 21898409 [TBL] [Abstract][Full Text] [Related]
7. Expression of stem-cell markers OCT-4 and CD133: important prognostic factors in papillary renal cell carcinoma. Kim K; Ro JY; Kim S; Cho YM Hum Pathol; 2012 Dec; 43(12):2109-16. PubMed ID: 22944295 [TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical expression of cancer stem cell related markers CD44 and CD133 in endometrial cancer. Elbasateeny SS; Salem AA; Abdelsalam WA; Salem RA Pathol Res Pract; 2016 Jan; 212(1):10-6. PubMed ID: 26608413 [TBL] [Abstract][Full Text] [Related]
9. CD44+/CD133+ immunophenotype and matrix metalloproteinase-9: Influence on prognosis in early-stage oral squamous cell carcinoma. Oliveira LR; Castilho-Fernandes A; Oliveira-Costa JP; Soares FA; Zucoloto S; Ribeiro-Silva A Head Neck; 2014 Dec; 36(12):1718-26. PubMed ID: 24178866 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of cancer stem cell markers in invasive breast carcinoma and associated ductal carcinoma in situ: relationships with markers of tumor hypoxia and microvascularity. Currie MJ; Beardsley BE; Harris GC; Gunningham SP; Dachs GU; Dijkstra B; Morrin HR; Wells JE; Robinson BA Hum Pathol; 2013 Mar; 44(3):402-11. PubMed ID: 23036368 [TBL] [Abstract][Full Text] [Related]
11. Colon cancer stem cell markers CD44 and CD133 in patients with colorectal cancer and synchronous hepatic metastases. Jing F; Kim HJ; Kim CH; Kim YJ; Lee JH; Kim HR Int J Oncol; 2015 Apr; 46(4):1582-8. PubMed ID: 25625240 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of CD133 based on microsatellite instability status in human colorectal cancer. Park JJ; Kwon JH; Oh SH; Choi J; Moon CM; Ahn JB; Hong SP; Cheon JH; Kim TI; Kim H; Kim WH Mol Carcinog; 2014 Feb; 53 Suppl 1():E1-10. PubMed ID: 23065858 [TBL] [Abstract][Full Text] [Related]
13. Co-expression of putative cancer stem cell markers, CD133 and Nestin, in skin tumors. Sabet MN; Rakhshan A; Erfani E; Madjd Z Asian Pac J Cancer Prev; 2014; 15(19):8161-9. PubMed ID: 25339000 [TBL] [Abstract][Full Text] [Related]
14. Expression of cancer stem cell markers in pancreatic intraepithelial neoplasias and pancreatic ductal adenocarcinomas. Kure S; Matsuda Y; Hagio M; Ueda J; Naito Z; Ishiwata T Int J Oncol; 2012 Oct; 41(4):1314-24. PubMed ID: 22824809 [TBL] [Abstract][Full Text] [Related]
15. The role of CD133 expression in the carcinogenesis and prognosis of patients with lung cancer. Le H; Zeng F; Xu L; Liu X; Huang Y Mol Med Rep; 2013 Nov; 8(5):1511-8. PubMed ID: 24008862 [TBL] [Abstract][Full Text] [Related]
16. CD133 expression is associated with poor outcome in neuroblastoma via chemoresistance mediated by the AKT pathway. Sartelet H; Imbriglio T; Nyalendo C; Haddad E; Annabi B; Duval M; Fetni R; Victor K; Alexendrov L; Sinnett D; Fabre M; Vassal G Histopathology; 2012 Jun; 60(7):1144-55. PubMed ID: 22394107 [TBL] [Abstract][Full Text] [Related]
17. Co-expression of CD133(+)/CD44(+) in human colon cancer and liver metastasis. Bellizzi A; Sebastian S; Ceglia P; Centonze M; Divella R; Manzillo EF; Azzariti A; Silvestris N; Montemurro S; Caliandro C; De Luca R; Cicero G; Rizzo S; Russo A; Quaranta M; Simone G; Paradiso A J Cell Physiol; 2013 Feb; 228(2):408-15. PubMed ID: 22740326 [TBL] [Abstract][Full Text] [Related]
18. Co-expression of stem cell genes CD133 and CD44 in colorectal cancers with early liver metastasis. Huang X; Sheng Y; Guan M Surg Oncol; 2012 Jun; 21(2):103-7. PubMed ID: 21764578 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic significance of putative stem cell marker, CD44 and CD133, in human gastric carcinoma. Chen S; Hou JH; Feng XY; Zhang XS; Zhou ZW; Yun JP; Chen YB; Cai MY J Surg Oncol; 2013 Jun; 107(8):799-806. PubMed ID: 23609373 [TBL] [Abstract][Full Text] [Related]
20. Epithelial mesenchymal transition correlates with CD24+CD44+ and CD133+ cells in pancreatic cancer. Zhang Y; Wei J; Wang H; Xue X; An Y; Tang D; Yuan Z; Wang F; Wu J; Zhang J; Miao Y Oncol Rep; 2012 May; 27(5):1599-605. PubMed ID: 22322379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]